[Asia Economy Reporter Lee Seon-ae]
◆Cellid=Approval of IND for Phase 2b clinical trial of COVID-19 preventive vaccine AdCLD-CoV19-1
◆Jinsung TEC=Acquisition of 2,769,998 shares of Thai subsidiary, investment of 10 billion KRW
◆Areus=Change of largest shareholder from Park Rae-seong to Shin Doo-young
◆Bioneer=Approval from Ministry of Food and Drug Safety for export of COVID-19 Delta and Omicron differentiation diagnostic kits
◆LIS=Early acquisition of 4 billion KRW 24th series bearer unsecured private convertible bonds
◆Ewon Compotech=Acquisition and resale of 5 billion KRW 3rd series bearer unsecured private convertible bonds
◆Ginaine Pharm=Reviewing third-party allotment capital increase and convertible bond issuance
Hot Picks Today
"Why Is the Korean Stock Market Surging?"... Even Italy Is Astonished by the KOSPI Rally
- "Invested 95% in Hynix and Reached 10 Billion Won"... Japanese Investor's Proof Post Goes Viral
- "South Korea Shows Similar Trend to Developed Nations"...Obesity Analysis of 232 Million People Worldwide [Reading Science]
- "You Don't Need to Go to the Gym": The Best Exercises for Lowering Hypertension
- "That Thing Wakes Up Every Night" ... Suspicious Object Covers Rural Village
◆Yujin Enterprise=Investment of 8 billion KRW in related party Nanum Lotto
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
